transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
, e.g., supermarket, food and restaurants (only for takeaway), drug stores. Online sales continued to grow remarkably by 150.0% YoY. Gross profit margin from sale of goods improved outstandingly to
% yoy, due to decrease of revenue. Food Business The Company started to invest in food business towards the end of 1Q18 by investing in 25.9% of shares in NR Instant Produce Company Limited (NRIP), which
machine and distributes the machine by cash and installment selling plans to customers 2. The company's group distributes beverages and instant foods through "Vending Plus" machine 3. The company's group
statements for the year 2023 and Q3 of 2024 19/12/2024 NR INSTANT PRODUCE PUBLIC COMPANY LIMITED SEC notifies NRF to cooperate with the auditor and rectify its interim financial statements 19/11/2024 NUSASIRI
baht or 6. 56 percent from the previous year, mainly due to a decrease of drug and medical supply cost since the volume of general patients and social security patients decreased. Besides, the Company